MarginsXMarginsX
Home › Markets › MRMD

Marimed Inc. (MRMD)

MRMD is quoted over the counter, not listed on an exchange. Marimed Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Close · November 16, 2026
$0.0626
-10.6% on the day
1-year return
-25.5%
Market cap
$25.4M
Nano cap. From the Nov 16, 2026 close × 406M shares (10-Q cover page, Nov 10, 2026)
P/E and P/S
Net loss over the period · 0.2×
On trailing twelve months to September 30, 2026 (10-Q)

Closes: Yahoo Finance daily closes, last bar 2026-11-16.

Profile

FieldValue
TickerMRMD, quoted over the counter
SEC CIK0001522767
OTC Markets tierOTCQB (price source, 2026-11-13)
SEC industry codeMedicinal Chemicals & Botanical Products
Business addressNorwood, MA
Incorporated inDE

Warning signs

Cash runway
Cash-flow positive
$10.4M cash at September 30, 2026
Share count, 1 year
+2.8%
2025-11-03 to 2026-11-10 · +7.9% over 3 years
Going-concern doubt
No
10-Q filed November 13, 2026
Insider net buying, 12 months
$13K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-13
Cash and burn$10.4M cash; operating cash flow $2.5M a quarter.Report 2026-09-30
Shares outstanding405,996,010 (2026-11-10); 395,073,625 a year earlier; 376,121,958 three years earlier.Cover page 2026-11-10
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorM&K CPAS, PLLC, The Woodlands, Texas, United StatesPCAOB Form AP 2026-03-20
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $13K, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$44.2M-$3.5M$3.5M$10.4M$81.9M$167.3M10-Q 2026-11-13
Q2 2026
2026-06-30
$41.9M-$3.6M$2.2M$8.4M$82.7M$163.8M10-Q 2026-08-13
Q1 2026
2026-03-31
$39.5M-$3.8M$949K$7.9M$82.5M$161.4M10-Q 2026-05-14
Q4 2025
2025-12-31
$41.6M-$4.6M$3.4M$8.9M$76.0M$159.8M10-K 2026-03-12
Q3 2025
2025-09-30
$40.8M-$2.9M$2.7M$6.6M$76.2M$157.1M10-Q 2026-11-13
Q2 2025
2025-06-30
$39.5M-$1.4M$297K$6.1M$77.5M$157.0M10-Q 2026-08-13
Q1 2025
2025-03-31
$37.9M-$5.5M$1.3M$7.2M$77.4M$157.9M10-Q 2026-05-14
Q4 2024
2024-12-31
$38.9M-$8.3M-$413K$7.3M$78.2M$157.9M10-K 2026-03-12

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B32021-04-28
Latest annual report10-K2026-03-12
Latest quarterly / interim10-Q2026-11-13
Latest current report8-K2026-11-12
Latest proxyDEF 14A2026-09-22

Source: SEC EDGAR submissions feed, 380 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier